PRPL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
PRPL is not a good buy right now. The trend is clearly bearish (bearish moving averages and weakening MACD), price is sitting right on key support (~0.698), and there are no proprietary buy signals or near-term catalysts. Given an impatient, “buy now” mindset, this setup is more likely to chop or break support than deliver a clean upside move.
Price/levels: PRPL is trading at ~0.701, essentially on S1 (0.698). A clean bounce would need reclaiming the pivot (0.742) and then R1 (0.786), but the current structure is weak. Trend: Bearish (SMA_200 > SMA_20 > SMA_5), signaling sustained downside pressure. Momentum: MACD histogram is negative (-0.0023) and expanding negatively, implying downside momentum is strengthening, not stabilizing. RSI: RSI(6) ~35.7 (weak/near-oversold but not signaling a confirmed reversal). Pattern-based near-term odds: Similar-pattern stats suggest only small expected moves (next day ~0.65%, next week ~0.33%, next month ~0.52%), which is not attractive given the downside risk at support.
Intellectia Proprietary Trading Signals
suggests some market participants are positioned for upside.
Technical trend remains decisively bearish (SMA stack bearish; MACD negative and deteriorating), increasing the odds that support breaks.
Profitability is worsening: 2025/Q3 net income fell to -$11.72M (down ~70% YoY) and EPS to -0.11 (down ~69% YoY).
No news in the past week and no visible event-driven catalysts to force a reversal.
Options market implies extreme uncertainty (very high IV), and volume is too low to confirm bullish sentiment.
Latest quarter: 2025/Q3. Revenue: $118.77M, essentially flat (+0.14% YoY). Profitability: Net income -$11.72M (worse YoY), EPS -0.11 (worse YoY). Margins: Gross margin improved to 42.82% (+5.68% YoY), which is the main positive, but it hasn’t translated into bottom-line improvement yet. Overall: Slightly better gross profitability, but earnings deterioration and flat revenue do not support a confident near-term “buy now” thesis.
No analyst rating or price-target change data was provided, so no recent Wall Street trend can be confirmed from this dataset. With available information, the main ‘pro’ case would be margin improvement and potential mean-reversion from support, while the ‘con’ case is the dominant downtrend and worsening losses—tilting the balance negative.
